Birzeit Pharmaceuticals Company (PEX:BPC)
Palestine · Delayed Price · Currency is JOD · Price in USD 3.710
0.00 (0.00%)
At close: Jul 8, 2026
PEX:BPC Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 12.59 | 11.95 | 5.18 | 6.12 | 7.95 | 12.08 |
Depreciation & Amortization | 1.41 | 1.41 | 1.42 | 1.5 | 1.66 | 1.66 |
Loss (Gain) From Sale of Assets | -0 | -0 | 0 | -0.05 | -0.05 | -0.16 |
Asset Writedown & Restructuring Costs | - | - | - | - | 0.69 | -0.27 |
Loss (Gain) From Sale of Investments | 0.24 | -0.04 | 1.63 | 1.24 | -0.88 | -2.03 |
Provision & Write-off of Bad Debts | 0.21 | 0.21 | - | 0.85 | 0.21 | 0.17 |
Other Operating Activities | 2.02 | 1.87 | 0 | 1.73 | 1.08 | 2.21 |
Change in Accounts Receivable | -18.23 | -10.36 | -5.78 | -0.04 | -5.21 | -10.55 |
Change in Inventory | -1.31 | -0.93 | 1.3 | -0.93 | -0.55 | 0.54 |
Change in Accounts Payable | -0.56 | -0.56 | 4.67 | - | - | - |
Change in Other Net Operating Assets | 6.17 | -1.21 | -1.46 | 1.77 | 0.3 | -0.01 |
Operating Cash Flow | 2.53 | 2.34 | 6.96 | 12.16 | 5.21 | 3.65 |
Operating Cash Flow Growth | -65.85% | -66.44% | -42.79% | 133.66% | 42.70% | -35.22% |
Capital Expenditures | -1.64 | -2.33 | -1.52 | -3.33 | -3.59 | -0.93 |
Sale of Property, Plant & Equipment | 0 | 0.02 | - | - | 0.05 | - |
Cash Acquisitions | -0.04 | - | -0.02 | -0.13 | - | -0.01 |
Divestitures | 0.09 | 0.09 | - | - | 0.01 | - |
Sale (Purchase) of Real Estate | - | - | - | 0.32 | - | 0.96 |
Investment in Securities | -1.07 | -0.71 | -3.49 | -3.86 | 3.48 | -1.13 |
Investing Cash Flow | -2.66 | -2.94 | -5.04 | -7.01 | -0.05 | -1.11 |
Long-Term Debt Repaid | - | - | - | -1.22 | -0.82 | -1.17 |
Net Debt Issued (Repaid) | 1.2 | - | - | -1.22 | -0.82 | -1.17 |
Issuance of Common Stock | - | - | 0 | 0 | - | - |
Repurchase of Common Stock | -0.02 | -0.01 | - | - | -0.08 | -0.01 |
Common Dividends Paid | -1.94 | -1.94 | -1.94 | -3.88 | -1.94 | -2.85 |
Financing Cash Flow | -0.75 | -1.94 | -1.94 | -5.09 | -2.84 | -4.03 |
Foreign Exchange Rate Adjustments | 0.51 | 0.5 | -0.02 | 0.05 | -0.45 | 0.07 |
Net Cash Flow | -0.36 | -2.05 | -0.04 | 0.11 | 1.86 | -1.42 |
Free Cash Flow | 0.89 | 0 | 5.43 | 8.83 | 1.62 | 2.72 |
Free Cash Flow Growth | -80.95% | -99.93% | -38.45% | 446.04% | -40.51% | -47.00% |
Free Cash Flow Margin | 1.81% | 0.01% | 13.37% | 20.47% | 3.44% | 5.98% |
Free Cash Flow Per Share | 0.02 | - | 0.14 | 0.23 | 0.04 | 0.07 |
Cash Income Tax Paid | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | - |
Levered Free Cash Flow | -4.37 | -4.82 | 4.76 | 5.21 | -0.98 | -1.17 |
Unlevered Free Cash Flow | -4.34 | -4.79 | 4.78 | 5.27 | -0.91 | -1.04 |
Change in Working Capital | -13.94 | -13.06 | -1.28 | 0.79 | -5.46 | -10.02 |